April 2026 in “Zenodo (CERN European Organization for Nuclear Research)”
This article promotes the use of Hair Boost Serum in the UK, describing its benefits for enhancing hair growth, reducing hair fall, and improving hair and scalp health through nourishing ingredients, but does not report any specific research findings.
June 2023 in “Zenodo (CERN European Organization for Nuclear Research)”
This review discusses the transformative potential of direct-to-consumer (DTC) hair regrowth solutions and reports no clinical results; it emphasizes innovation, personalization, and trust in reshaping the industry.
1 citations
,
May 2022 in “International Journal of Trichology”
This article discusses hair loss conditions and available camouflage options after medical and surgical interventions fail, but it reports no new clinical findings.
Azelaic acid is discussed for its anti-inflammatory and anti-fungal properties, which can improve scalp health and potentially boost hair growth. It is suggested for topical use, especially alongside minoxidil.
The user is using Minoxidil 5% foam in the morning and a Minoxidil 5% + Finasteride 1% solution in the evening for hair loss. They are seeking advice on additional topical treatments to use midday, such as caffeine serums, peptides, Redensyl, or natural anti-inflammatories.
A 28-year-old male is experiencing severe hair loss and is considering finasteride after his doctor prescribed hair growth serum, minoxidil, and Boostsolution. Some suggest consulting another doctor for a finasteride prescription, while others share personal success with finasteride.
Minoxidil and tretinoin can cause scalp dryness and itchiness. Using Nizoral, aloe, a lighter minoxidil formula, or a water-based moisturizer like one with hyaluronic acid may help alleviate these issues.
Clascoterone 5% solution is discussed as a potential new treatment for hair loss, offering an alternative for those who can't use finasteride or need additional options beyond minoxidil. Concerns about cost, effectiveness, and safety compared to existing treatments like RU58841 and finasteride are highlighted.